BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 21200182)

  • 1. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    McDonald-McGinn DM; Sullivan KE
    Medicine (Baltimore); 2011 Jan; 90(1):1-18. PubMed ID: 21200182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DiGeorge syndrome/velocardiofacial syndrome: the chromosome 22q11.2 deletion syndrome.
    Sullivan KE
    Adv Exp Med Biol; 2007; 601():37-49. PubMed ID: 17712990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.
    Sullivan KE
    Immunol Allergy Clin North Am; 2008 May; 28(2):353-66. PubMed ID: 18424337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 22q11.2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes.
    Cuneo BF
    Curr Opin Pediatr; 2001 Oct; 13(5):465-72. PubMed ID: 11801894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net!
    McDonald-McGinn DM; Tonnesen MK; Laufer-Cahana A; Finucane B; Driscoll DA; Emanuel BS; Zackai EH
    Genet Med; 2001; 3(1):23-9. PubMed ID: 11339373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DiGeorge syndrome: new insights.
    Goldmuntz E
    Clin Perinatol; 2005 Dec; 32(4):963-78, ix-x. PubMed ID: 16325672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DiGeorge anomaly (CATCH 22, DiGeorge/velocardiofacial syndrome).
    Hong R
    Semin Hematol; 1998 Oct; 35(4):282-90. PubMed ID: 9801257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes).
    Perez E; Sullivan KE
    Curr Opin Pediatr; 2002 Dec; 14(6):678-83. PubMed ID: 12436034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes.
    Kobrynski LJ; Sullivan KE
    Lancet; 2007 Oct; 370(9596):1443-52. PubMed ID: 17950858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease.
    Staple L; Andrews T; McDonald-McGinn D; Zackai E; Sullivan KE
    Pediatr Allergy Immunol; 2005 May; 16(3):226-30. PubMed ID: 15853951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DiGeorge syndrome/chromosome 22q11.2 deletion syndrome.
    Sullivan KE
    Curr Allergy Asthma Rep; 2001 Sep; 1(5):438-44. PubMed ID: 11892070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    Smith CA; Driscoll DA; Emanuel BS; McDonald-McGinn DM; Zackai EH; Sullivan KE
    Clin Diagn Lab Immunol; 1998 May; 5(3):415-7. PubMed ID: 9606003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital heart defects in patients with DiGeorge/velocardiofacial syndrome and del22q11.
    Marino B; Digilio MC; Toscano A; Giannotti A; Dallapiccola B
    Genet Couns; 1999; 10(1):25-33. PubMed ID: 10191426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome).
    Sullivan KE; McDonald-McGinn DM; Driscoll DA; Zmijewski CM; Ellabban AS; Reed L; Emanuel BS; Zackai EH; Athreya BH; Keenan G
    Arthritis Rheum; 1997 Mar; 40(3):430-6. PubMed ID: 9082929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility gene card for: DiGeorge syndrome, velocardiofacial syndrome, Shprintzen syndrome, chromosome 22q11.2 deletion syndrome (22q11.2, TBX1).
    Schwinger E; Devriendt K; Rauch A; Philip N
    Eur J Hum Genet; 2010 Sep; 18(9):. PubMed ID: 20125192
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    Perez EE; Bokszczanin A; McDonald-McGinn D; Zackai EH; Sullivan KE
    Pediatrics; 2003 Oct; 112(4):e325. PubMed ID: 14523220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent de novo 22q11.2 deletions in first cousins with DiGeorge/velocardiofacial syndrome.
    Saitta SC; Harris SE; McDonald-McGinn DM; Emanuel BS; Tonnesen MK; Zackai EH; Seitz SC; Driscoll DA
    Am J Med Genet A; 2004 Jan; 124A(3):313-7. PubMed ID: 14708107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic basis of DiGeorge and velocardiofacial syndromes.
    Driscoll DA
    Curr Opin Pediatr; 1994 Dec; 6(6):702-6. PubMed ID: 7849818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome.
    Sullivan KE
    Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):505-12. PubMed ID: 15640691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes.
    Sullivan KE; Jawad AF; Randall P; Driscoll DA; Emanuel BS; McDonald-McGinn DM; Zackai EH
    Clin Immunol Immunopathol; 1998 Feb; 86(2):141-6. PubMed ID: 9473376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.